Kymera Therapeutics, Inc. · NASDAQ:KYMR

Chadwick Jeremy G sold 300 Kymera Therapeutics, Inc. shares (Form 4)

Traded Apr 22, 2026 · Filed Apr 24, 2026

On Apr 22, 2026, Chadwick Jeremy G (Chief Operating Officer) sold 300 Kymera Therapeutics, Inc. shares at US$90.00 for US$27,000 under a trading plan, leaving 61,202 shares. Filed Apr 24, 2026 (Form 4).

Sold
300 shares
Price
US$90.00
Value
US$27,000
Holding after
61,202 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 22, 2026Common StockOption exercise100US$30.1761,302Direct
Apr 22, 2026Common StockOption exercise200US$43.5061,502Direct
Apr 22, 2026Common StockSale300US$90.0061,202Direct

Source

View original at SEC

Related